{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T04:31:37Z","timestamp":1692160297827},"reference-count":9,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,8,15]]},"abstract":"<jats:p>A nonsmoking patient with gastroesophageal reflux disease and Raynaud disease had 4 weeks of dysphagia and a 4.54-kg weight loss over 3 months, cough productive of yellow sputum, and dyspnea on exertion. White blood cell count and creatine kinase and aldolase levels were elevated; antinuclear antibody assay findings were positive; and chest CT showed bibasilar pulmonary consolidations and ground glass opacities. What is the diagnosis and what would you do next?<\/jats:p>","DOI":"10.1001\/jama.2023.13766","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T15:31:52Z","timestamp":1690471912000},"page":"658","source":"Crossref","is-referenced-by-count":0,"title":["Patient With Pulmonary Symptoms, Dysphagia, and Raynaud Disease"],"prefix":"10.1001","volume":"330","author":[{"given":"Aisha","family":"Ghias","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, NYU Langone Health, Mineola, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalinee","family":"Chawla","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, NYU Langone Health, Mineola, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Agarwala","sequence":"additional","affiliation":[{"name":"NYU Langone Health, Mineola, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"12","key":"jcg230011r1","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"jcg230011r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101503","article-title":"Clinical manifestations and treatment of antisynthetase syndrome.","volume":"34","author":"Marco","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"jcg230011r3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.872615","article-title":"Clinical features, prognostic factors, and survival of patients with antisynthetase syndrome and interstitial lung disease.","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"jcg230011r4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/2397198320902667","article-title":"Antisynthetase syndrome: a distinct disease spectrum.","volume":"5","author":"Huang","year":"2020","journal-title":"J Scleroderma Relat Disord"},{"issue":"5","key":"jcg230011r5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/CPM.0000000000000171","article-title":"The diagnosis and treatment of antisynthetase syndrome.","volume":"23","author":"Witt","year":"2016","journal-title":"Clin Pulm Med"},{"issue":"7","key":"jcg230011r6","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s10067-023-06570-3","article-title":"Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome\u2013associated interstitial lung disease.","volume":"42","author":"Fu","year":"2023","journal-title":"Clin Rheumatol"},{"issue":"11","key":"jcg230011r7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/jcm8112013","article-title":"Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course.","volume":"8","author":"Cavagna","year":"2019","journal-title":"J Clin Med"},{"issue":"6","key":"jcg230011r8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","article-title":"A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in Black patients and patients with anti-PL7 and anti-PL12 autoantibodies.","volume":"56","author":"Pinal-Fernandez","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"jcg230011r9","article-title":"Efficacy and tolerability of nintedanib in idiopathic-inflammatory-myopathy-related interstitial lung disease: a pilot study.","volume":"8","author":"Liang","year":"2021","journal-title":"Front Med (Lausanne)"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2807957\/jama_ghias_2023_cg_230011_1691609320.2922.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:33:59Z","timestamp":1692113639000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2807957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,8,15]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.13766","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,15]]}}}